[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355149-105":59,"doc-detail-355149-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-emerging-role-of-m6a-methylation-in-prostate-related-diseases-mechanisms-and-clinical-implications","The emerging role of m6A methylation in prostate-related diseases - mechanisms and clinical implications","","Prostate-related diseases affecting aging men worldwide, including prostatitis, benign prostatic hyperplasia, and prostate cancer, remain mechanistically unresolved despite their high prevalence. This review consolidates evidence that N6-methyladenosine (m6A) RNA modification regulates prostate disease progression through coordinated m6A writers, erasers, and readers. Dysregulated m6A signaling reshapes proliferation, differentiation, inflammatory signaling, and stem cell dynamics while modulating prostate cancer immune suppression, biomarker discovery, and m6A-targeted therapeutic opportunities.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-emerging-role-of-m6a-methylation-in-prostate-related-diseases-mechanisms-and-clinical-implications/355149/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-emerging-role-of-m6a-methylation-in-prostate-related-diseases-mechanisms-and-clinical-implications/355149.png","ImageObject",300,407,{"name":92,"@type":93},"Theodore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the central focus of this review?","Question",{"text":112,"@type":113},"The review summarizes how m6A RNA methylation contributes to the mechanisms and clinical implications of prostate-related diseases, including prostatitis, benign prostatic hyperplasia, and prostate cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which components of the m6A system are discussed?",{"text":117,"@type":113},"It covers m6A writers such as the METTL3-METTL14 complex, erasers including FTO and ALKBH5, and readers from YTH-domain proteins, IGF2BPs, and HNRNPs.",{"name":119,"@type":110,"acceptedAnswer":120},"How does dysregulated m6A affect prostate cancer therapy and immunity?",{"text":121,"@type":113},"m6A imbalance can shape an immunosuppressive landscape by altering immune checkpoint expression, cytokine networks, and immune cell infiltration, which in turn influences responses to immunotherapy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355149,1790615896,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","TYPE Review  \nPUBLISHED 12 February 2026  \nDOI 10.3389/fimmu.2026.1685015  \nOPEN ACCESS  \nEDITED BY  \nStefano Marletta,  \nUniversity of Verona, Italy  \nREVIEWED BY  \nVaibhavi V. Gujar,  \nNational Institutes of Health (NIH), United States  \nJingjing Li,  \nShandong Second Medical University, China Yumin Wang,  \nAerospace Center Hospital, China  \n*CORRESPONDENCE  \nXinrong Fan  \n [fanxinrong@merc.ac.cn](fanxinrong@merc.ac.cn)[ ](fanxinrong@merc.ac.cn)Danping Fan  \n [fandanping@merc.ac.cn](fandanping@merc.ac.cn)  \nRECEIVED 13 August 2025  \nREVISED 07 January 2026  \nACCEPTED 19 January 2026  \nPUBLISHED 12 February 2026  \nCITATION  \nXie Q, Zhao H, Yang X, Zhang H, Liu H, Pan J, Li Y, Fan D and Fan X (2026) The emerging role of m6A methylation in prostate-related diseases: mechanismsand clinical implications.  \nFront. Immunol. 17:1685015 .  \ndoi: 10.3389/fimmu.2026.1685015  \nCOPYRIGHT  \n© 2026 Xie, Zhao, Yang, Zhang, Liu, Pan, Li, Fan and Fan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nThe emerging role of m 6Amethylation in prostate-related diseases: mechanisms and clinical implications  \nQinghua Xie, Hongyan Zhao, Xuan Yang, Hongqi Zhang, Hong Liu, Jinghua Pan, Yan Li, Danping Fan* and Xinrong Fan* Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing, China  \nProstate-related diseases, including prostatitis, benign prostatic hyperplasia (BPH), and prostate cancer (PCa), represent signiﬁcant threats to the health of the aging male population worldwide. Despite their prevalence, the pathogenesis of prostate-related diseases has not been elucidated. Recent studies have shown that N 6-methyladenosine (m 6A) modiﬁcation is widely involved in the progression of prostate-related diseases. In this review, we summarized recent advances in understanding the core m6A regulatory machinery comprising writers such as the methyltransferase-like 3 (METTL3)-METTL14 complex, erasers including fat mass and obesity-associated protein (FTO) and AlkB homolog 5 (ALKBH5), and readers, including the YTH domain-containing family proteins (YTHDFs), YTHDC proteins, insulin-like growth factor 2 mRNAbinding proteins (IGF2BPs), and heterogeneous nuclear ribonucleoproteins (HNRNPs) . Speciﬁcally, we elucidated how dysregulation of these components drives disease progression via alterations in cellular proliferation, differentiation, inﬂammatory responses, and stem cell dynamics. Notably, m6A modiﬁcations help shape the immunosuppressive landscape in PCa by modulating immune checkpoint expression, cytokine networks, and immune cell inﬁltration, thereby critically inﬂuencing therapeutic responses to immunotherapy. Furthermore, this review highlights the emerging diagnostic potential and therapeutic viability of m6A-targeted strategies, offering valuable insights for future clinical translation in prostate-related diseases.  \nKEYWORDS  \nbenign prostatic hyperplasia, m6A methylation modiﬁcation, prostate cancer, prostate-related diseases, prostatitis  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \nXie et al. 10.3389/fimmu.2026.1685015  \nGRAPHICAL ABSTRACT  \nN6-methyladenosine (m6A) RNA methylation dynamically orchestrates prostate physiology and pathology through the coordinated actions of writers (e. g., METTL3, METTL14, and WTAP), erasers (FTO and ALKBH5), and readers (YTHDF1, YTHDF2, YTHDC1), which together regulate mRNA stability, splicing, translation, and decay. This epitranscriptomic machinery modulates key cellular processes, including proliferation, differentiation, inﬂammatory responses, and stemness, within the","cbCaivxkq16qX4W8","https://ap.wps.com/l/cbCaivxkq16qX4W8","pdf",3502451,"English","# Introduction\n## m6A regulatory machinery in prostate-related diseases\n## m6A and disease progression: inflammation, proliferation, differentiation\n## m6A and immune microenvironment in prostate cancer\n## Diagnostic biomarkers and therapeutic implications","[{\"question\":\"What is the central focus of this review?\",\"answer\":\"The review summarizes how m6A RNA methylation contributes to the mechanisms and clinical implications of prostate-related diseases, including prostatitis, benign prostatic hyperplasia, and prostate cancer.\"},{\"question\":\"Which components of the m6A system are discussed?\",\"answer\":\"It covers m6A writers such as the METTL3-METTL14 complex, erasers including FTO and ALKBH5, and readers from YTH-domain proteins, IGF2BPs, and HNRNPs.\"},{\"question\":\"How does dysregulated m6A affect prostate cancer therapy and immunity?\",\"answer\":\"m6A imbalance can shape an immunosuppressive landscape by altering immune checkpoint expression, cytokine networks, and immune cell infiltration, which in turn influences responses to immunotherapy.\"}]","The emerging role of m6A methylation in prostate-related diseases - mechanisms and clinical implications | PDF",1790116348,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a345cfde2df81357e95cec1e71d2f317.webp",983,1389,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3c68d05348a87737f6e81d4c2e8cf9f7.webp",982,1388,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b83f629cb3138e4a8a7af7b87ef24485.webp",981,1386,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a00b4734031b3a1ec07eade7c9e29e83.webp",980,1385]